GlaxoSmithKline Plc (GSK.L) executive Mark Reilly had little inkling he would be charged with leading a network of corruption in China’s pharmaceutical industry, two sources with ties to the businessman and knowledge of the investigation said.
The allegations against the Briton, who as GSK’s China head was the firm’s legal representative in the country, are the most serious charges ever laid against a foreign national for corporate corruption in China, lawyers said.
Police said they had charged Reilly and two Chinese colleagues with multiple offences on Wednesday after a 10-month probe found the firm made billions of yuan from schemes to bribe doctors and hospitals.
Read Full Article HERE
Adam Jourdan and Kazunori Takada, Reuters via CHINA US Focus http://ift.tt/T6M9ch
No comments:
Post a Comment